EC |
EU Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01) | EC | Nov-2013 | [English] |
EU Good Distribution Practice of Active Substances for Medicinal Products for Human Use ( 2015/C 95/01 ) | EC | Mar-2015 | [English] |
HPRA |
HPRA Guide to Good Distribution Practice of Medicinal Products for Human Use (9 MAY 2019) | HPRA | May-2019 | [English] |
MHRA |
Exceptional good distribution practice (GDP) flexibilities for medicines during the coronavirus (COVID-19) outbreak | MHRA | Apr-2020 | [na] |
US FDA |
Guidance for Industry, Product Identifier Requirements Under the Drug Supply Chain Security Act - Compliance Policy | US FDA | Sep-2018 | [English] |
WHO |
WHO Good Trade and Distribution Practices for Pharmaceutical Starting Materials. WHO Technical Report Series, No. 996, 2016, Annex 6 | WHO | 2016 | [English] |
WHO Good Distribution Practices for Pharmaceutical Products. WHO Technical Report Series, No. 957, 2010, Annex 5 | WHO | 2010 | [English] |
WHO Guide to good storage practices for pharmaceuticals. WHO Technical Report Series, No. 908, 2003, Annex 9 | WHO | 2003 | [English] |